The Silicon Review
Although Artificial intelligence (AI) is touching every sphere of our lives, especially in the healthcare domain, its impact is truly life changing. Secondary research reveals, jointly public and private sector investment in healthcare is expected to reach $6.6 billion by 2021, encompassing areas such as healthcare, clinical research, drug development and insurance. Although human physicians will not be replaced by AI doctors however, AI will definitely prove useful in simplifying clinical decision especially in the area of radiology.
Through imitation of human cognitive functions, it enhances the sector’s availability of both, structured such as image, genetic and electrophysiological data and unstructured data such as clinical notes and medical journals and also analytical techniques through machine learning and natural language processing (NLP), respectively. In healthcare, AI is effective in areas of early detection, diagnosis, treatment, prediction and prognosis evaluation in diseases such as cancer, neurology and cardiology. Through application of big data analytics, one can gather relevant information from piles of healthcare data, such insight can assist in clinical decisions. Also, AI helps incorporate self-correcting abilities and facilitates auto updation of medical information in different healthcare devices.
Viz.ai is the leader in AI-driven modern care coordination. Viz.ai’s mission is to fundamentally improve how healthcare is delivered in the world, through intelligent software that promises to reduce time to treatment, improve access to care, and increase the speed of diffusion of medical innovation. Viz.ai’s flagship product, Viz LVO, leverages advanced deep learning to communicate time-sensitive information about stroke patients straight to a specialist who can intervene and treat. The company’s AI powered products detects and alerts stroke teams to suspected large vessel occlusion strokes, as well as completed CT perfusion studies, in their network within minutes. Stroke teams can consult in real time via a HIPAA-compliant mobile interface, driving fast treatment decisions that save brain and save lives.
Industry-Leading Applied AI-based Healthcare Products Offered
HIPAA-Compliant Communication Platform: The Viz HIPAA-compliant text messaging and calling platform empowers clinical teams to conveniently coordinate patient care and treatment decisions in a single hospital and more complex networks. Viz coordinates care by connecting frontline HCPs to specialists earlier in the workflow enabling activation of care teams sooner, and streamlining the consultation process. Its Proprietary compression software enables immediate and dynamic mobile image viewing using wifi or your cellular network. Viz HUB is a secure, HIPAA-compliant text messaging and calling platform that empowers clinical teams to conveniently coordinate patient care and treatment decisions between hospitals in a hub and spoke network. first HIPAA-compliant communication platform designed to synchronize stroke care in a hub and spoke network.
Viz LVO: The first FDA-cleared technology indicated to automatically detect and triage suspected LVOs using A.I. Viz LVO uses artificial intelligence to automatically detect suspected LVOs on CTA imaging and directly alert the on-call stroke specialists¹ about potentially treatable patients across a multi-hospital network. The Viz Platform automates the cryptogenic referral process by enabling in-app referrals from neurology to cardiology allowing centers to better capture appropriate patients for long term monitoring without introducing new manual workflows.
Viz Cryptogenic Workflow: 30 percent of acute ischemic strokes are cryptogenic, meaning the cause is unknown. Cardiac monitoring is critical in these patients as irregular heart rhythm is often the root cause. Viz.ai is using technology to streamline this care pathway. Boca Raton Regional Hospital invested heavily in optimizing their cryptogenic stroke protocol. This effort resulted in increasing their rate of long term monitoring via loop recorder implants. Viz LINK uses technology to help automate this typically manual workflow. Viz connects neurology and cardiology to facilitate cryptogenic follow up. A consult/referral for continuous monitoring for atrial fibrillation can be made directly within the app.
Viz IC: It can detect and alert about patients throughout your hub and spoke network that can benefit from a neurosurgical treatment. It enables increased access to early surgical intervention which is associated with improved patient outcomes, decreased hospital length of stay and decreased ventilator use. Viz ICH enables increased access to surgical intervention which is associated with decreased cost. It uses advanced imaging technology to automatically analyze CT perfusion images of the brain, produce parametric color maps, and calculate CT perfusion parameters.
The Visionary Leader
Dr. Chris Mansi, co-founder, serves as the Chief Executive Officer of Viz.ai.